Shunsuke Mori

Summary

Affiliation: National Hospital Organization
Country: Japan

Publications

  1. pmc Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, Kohshi, Kumamoto, Japan
    Ann Rheum Dis 72:1362-6. 2013
  2. ncbi request reprint Familial Mediterranean fever occurring in an elderly Japanese woman with recent-onset rheumatoid arthritis
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, Japan
    Intern Med 52:385-8. 2013
  3. pmc Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto 861 1196, Japan
    Rheumatology (Oxford) 51:2120-30. 2012
  4. pmc Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto 861 1196, Japan
    Ann Rheum Dis 71:2006-10. 2012
  5. doi request reprint Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto 861 1196, Japan
    Respir Med 106:1591-9. 2012
  6. pmc Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto 861 1196, Japan
    Mod Rheumatol 22:727-37. 2012
  7. doi request reprint Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto, 861 1196, Japan
    Mod Rheumatol 22:515-23. 2012
  8. doi request reprint Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection? : Case presentation and literature review
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto, 861 1196, Japan
    Clin Rheumatol 31:203-10. 2012
  9. pmc Primary lack of efficacy of infliximab therapy for rheumatoid arthritis: pharmacokinetic characterization and assessment of switching to tocilizumab
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto 861 1196, Japan
    Mod Rheumatol 21:628-36. 2011
  10. pmc Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs
    Shunsuke Mori
    Clinical Research Center for Rheumatic Disease, Department of Rheumatology, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto 861 1196, Japan
    Mod Rheumatol 21:621-7. 2011

Detail Information

Publications28

  1. pmc Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, Kohshi, Kumamoto, Japan
    Ann Rheum Dis 72:1362-6. 2013
    ..We assessed the impact of tocilizumab (TCZ), a humanised monoclonal anti-interleukin-6 receptor antibody, on antibody response following administration of the 23-valent pneumococcal polysaccharide vaccine (PPV23)...
  2. ncbi request reprint Familial Mediterranean fever occurring in an elderly Japanese woman with recent-onset rheumatoid arthritis
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, Japan
    Intern Med 52:385-8. 2013
    ..The clinical manifestations of FMF mimic infectious complications during anti-RA therapy. Clinicians should therefore consider the possibility of FMF development in RA patients exhibiting recurrent febrile attacks...
  3. pmc Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto 861 1196, Japan
    Rheumatology (Oxford) 51:2120-30. 2012
    ..jirovecii is effective in controlling PCP outbreaks among RA outpatients...
  4. pmc Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto 861 1196, Japan
    Ann Rheum Dis 71:2006-10. 2012
    ..We assessed the influence of tocilizumab (TCZ), a humanised monoclonal anti-interleukin-6 receptor antibody, on antibody response following influenza vaccination in patients with rheumatoid arthritis (RA)...
  5. doi request reprint Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto 861 1196, Japan
    Respir Med 106:1591-9. 2012
    ..To identify clinical and genetic risk factors for interstitial lung disease (ILD) or airway disease (AD) in patients with rheumatoid arthritis (RA) and to evaluate differences between the associations of these factors with ILD and AD...
  6. pmc Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto 861 1196, Japan
    Mod Rheumatol 22:727-37. 2012
    ..This study was performed to evaluate the radiological features of and therapeutic responses to pulmonary disease caused by nontuberculous mycobacteria (NTM) in the setting of biological therapy for rheumatoid arthritis (RA)...
  7. doi request reprint Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto, 861 1196, Japan
    Mod Rheumatol 22:515-23. 2012
    ....
  8. doi request reprint Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection? : Case presentation and literature review
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto, 861 1196, Japan
    Clin Rheumatol 31:203-10. 2012
    ..We review the medical literature on NTM disease associated with anti-TNFα therapy for rheumatic diseases and discuss the safety of simultaneous use of anti-TNFα agents in patients during anti-NTM therapy...
  9. pmc Primary lack of efficacy of infliximab therapy for rheumatoid arthritis: pharmacokinetic characterization and assessment of switching to tocilizumab
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto 861 1196, Japan
    Mod Rheumatol 21:628-36. 2011
    ....
  10. pmc Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs
    Shunsuke Mori
    Clinical Research Center for Rheumatic Disease, Department of Rheumatology, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto 861 1196, Japan
    Mod Rheumatol 21:621-7. 2011
    ..Regular monitoring of serum viral DNA seems to be the most rational approach to preventing the development of clinically apparent hepatitis...
  11. ncbi request reprint Minimal-change nephrotic syndrome associated with isoniazid in anti-tuberculosis chemoprophylaxis for a patient with rheumatoid arthritis
    Shunsuke Mori
    Clinical Research Center for Rheumatic Disease, Department of Rheumatology, NHO Kumamoto Saishunsou National Hospital, Japan
    Intern Med 50:253-7. 2011
    ....
  12. pmc Small airway obstruction in patients with rheumatoid arthritis
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto, 861 1196, Japan
    Mod Rheumatol 21:164-73. 2011
    ..Factors significantly associated with abnormal FEF(25-75) are respiratory symptoms, smoking history, and RA duration...
  13. doi request reprint Contribution of HLA-DRB1*04 alleles and anti-cyclic citrullinated antibodies to development of resistance to disease-modifying antirheumatic drugs in early rheumatoid arthritis
    Shunsuke Mori
    Clinical Research Center for Rheumatic Disease and Department of Rheumatology, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto 861 1196, Japan
    Clin Rheumatol 29:1357-66. 2010
    ..These observations show that the presence of SE-positive *04 alleles in combination with anti-CCP Abs is the strongest predictor for development of DMARD resistance and eventual need of anti-TNFα agents in patients with early RA...
  14. doi request reprint Acute respiratory distress syndrome associated with rapid aggravation of rheumatoid arthritis
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto, 861 1196, Japan
    Mod Rheumatol 20:77-80. 2010
    ..We should be alert to the possibility that ARDS can occur as an acute-type pulmonary complication of RA, particularly when patients show rapid aggravation of rheumatic activity...
  15. doi request reprint A followup study of asymptomatic carriers of Pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis
    Shunsuke Mori
    Clinical Research Center for Rheumatic Disease, NHO Kumamoto Saishunsou National Hospital, Kumamoto, Japan
    J Rheumatol 36:1600-5. 2009
    ..To examine the preventive effects of prophylaxis against Pneumocystis jiroveci-induced pneumonia (PCP) in patients receiving immunosuppressive therapy for rheumatoid arthritis (RA) who are colonized by this organism...
  16. ncbi request reprint Clinical characteristics of polymyalgia rheumatica in Japanese patients: evidence of synovitis and extracapsular inflammatory changes by fat suppression magnetic resonance imaging
    Shunsuke Mori
    Department of Rheumatology and Clinical Research Center for Rheumatic Disease, Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto, 861 1196, Japan
    Mod Rheumatol 17:369-75. 2007
    ..To avoid making a wrong diagnosis, we should be aware that peripheral synovitis is one of the hallmarks of PMR...
  17. ncbi request reprint Early rheumatoid arthritis in a patient with Sjögren's syndrome and pulmonary nodular amyloidosis: clinical implication of early limited use of infliximab
    Shunsuke Mori
    Clinical Research Center for Rheumatic Disease and Department of Rheumatology, Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto, 861 1196, Japan
    Mod Rheumatol 17:500-6. 2007
    ..An optimal and affordable strategy for the treatment of early RA should be developed. Our findings may support the idea that the combination therapy of infliximab and MTX for early RA alters the course of the disease...
  18. ncbi request reprint A simultaneous onset of organizing pneumonia and rheumatoid arthritis, along with a review of the literature
    Shunsuke Mori
    Clinical Research Center for Rheumatic Disease and Department of Rheumatology, Kumamoto Saishunsou National Hospital, Kumamoto, Japan
    Mod Rheumatol 18:60-6. 2008
    ..Since OP may progress to fibrotic lung disease during the course of RA, we may consider performing a second lung biopsy for steroid-resistant patients, even if they have once been diagnosed as OP...
  19. doi request reprint Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy
    Shunsuke Mori
    Clinical Research Center for Rheumatic Disease and Department of Rheumatology, Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto, Japan
    Mod Rheumatol 18:240-6. 2008
    ..By careful follow-up on the carriers of P. jiroveci, we succeeded in promptly diagnosing PCP, and we employed the appropriate therapeutic strategies for this possibly life-threatening complication...
  20. doi request reprint Delayed spinal infection after laminectomy in a patient with rheumatoid arthritis interruptedly exposed to anti-tumor necrosis factor alpha agents
    Shunsuke Mori
    Clinical Research Center for Rheumatic Disease and Department of Rheumatology, Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, 861 1196, Japan
    Clin Rheumatol 27:937-9. 2008
    ..Despite interruption of anti-TNFalpha therapy before surgery, patients may remain at risk of developing postoperative infections...
  21. doi request reprint A sudden onset of diabetic ketoacidosis and acute pancreatitis after introduction of mizoribine therapy in a patient with rheumatoid arthritis
    Shunsuke Mori
    Clinical Research Center for Rheumatic Disease and Department of Rheumatology, Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto, 861 1196, Japan
    Mod Rheumatol 18:634-8. 2008
    ..Through prompt diagnosis and treatment, the patient recovered from these extremely rare but potentially lethal complications...
  22. doi request reprint Diagnostic utility of anti-cyclic citrullinated peptide antibodies for rheumatoid arthritis in patients with active lung tuberculosis
    Shunsuke Mori
    Clinical Research Center for Rheumatic Disease and Department of Rheumatology, Kumamoto Saishunsou National Hospital, 2659 Suya, Kohshi, Kumamoto 861 1196, Japan
    Clin Rheumatol 28:277-83. 2009
    ..These observations show that measurement of anti-CCP2 seems to be a reliable serological tool for identifying early RA in patients with active tuberculosis...
  23. ncbi request reprint Methotrexate pneumonia lacking dyspnea and radiographic interstitial patterns during treatment for early rheumatoid arthritis: bronchoalveolar lavage and transbronchial lung biopsy in a differential diagnosis
    Isamu Cho
    Clinical Research Center for Rheumatic Disease and Division of Respiratory Medicine, Department of Medicine, Kumamoto Saishunsou National Hospital, Kumamoto, Japan
    Mod Rheumatol 17:256-61. 2007
    ....
  24. ncbi request reprint Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis
    Shunsuke Mori
    Department of Rheumatology, Kumamoto Saishunsou National Hospital, Kumamoto, Japan
    J Rheumatol 35:1513-21. 2008
    ..To identify the predominant radiological abnormalities in the lungs of patients with early rheumatoid arthritis (RA) and in those with longstanding RA...
  25. ncbi request reprint A relationship between pharmacokinetics (PK) and the efficacy of infliximab for patients with rheumatoid arthritis: characterization of infliximab-resistant cases and PK-based modified therapy
    Shunsuke Mori
    Department of Rheumatology, Clinical Research Center for Rheumatic Disease, National Kumamoto Saishunsou Hospital, 2659 Suya, Kohshi 861 1196, Japan
    Mod Rheumatol 17:83-91. 2007
    ..The addition of tacrolimus was effective to improve the clinical outcomes of nonresponders. Thus PK data apparently offer guidance when modified treatment for infliximab-resistant RA patients is being considered...
  26. ncbi request reprint Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor alpha-neutralizing antibody
    Shunsuke Mori
    Division of Rheumatology, Department of Medicine, National Hospital Organization, Kumamoto Saishunso National Hospital, 2659 Suya Kohshi, Kumamoto, 861 1196, Japan
    Mod Rheumatol 16:251-5. 2006
    ..Keeping a sharp lookout on IP development during this period is crucial to the success of infliximab treatment. After MTX discontinuation and steroid pulse therapy, our patient made a dramatic recovery from IP...
  27. ncbi request reprint Pneumocystis jiroveci pneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumor necrosis factor alpha neutralizing antibody
    Shunsuke Mori
    Division of Rheumatology, Department of Medicine, National Hospital Organization, Kumamoto Saishunso National Hospital, Suya 2659 Nishigohshi machi, Kikuchi gun, Kumamoto 860 1196, Japan
    Mod Rheumatol 16:58-62. 2006
    ..A polymerase chain reaction-based detection of Pneumocystis jiroveci in induced sputum allowed an early diagnosis of PCP and subsequent effective treatment...
  28. ncbi request reprint A case of metastatic extra-adrenal pheochromocytoma 12 years after surgery
    Shunsuke Mori
    Second Department of Internal Medicine, Ehime University School of Medicine, Japan
    Hypertens Res 25:141-4. 2002
    ..For post-operative pheochromocytoma, long-term follow-up involving biochemical tests, including serum catecholamines, and MIBG is needed...